Molecular cytogenetics: An indispensable tool for cancer diagnosis

Chang Gung Medical Journal

Volumn 35, Issue 2, 2012, Pages 96-110

  Wan, Thomas S K ^a   Ma, Edmond S K ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Array cgh; Comparative genomic hybridization; Fluorescence in situ hybridization; Molecular cytogenetics; Multicolor karyotyping

Indexed keywords

BLADDER CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RESEARCH; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CLINICAL LABORATORY; COMPARATIVE GENOMIC HYBRIDIZATION; CYTODIAGNOSIS; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA PROBE; DNA SEQUENCE; DUAL COLOR BREAK APART PROBE; DUAL COLOR TRANSLOCATION PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE IDENTIFICATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LEUKEMIA; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MULTICOLOR FLUORESCENCE IN SITU HYBRIDIZATION; NONHUMAN; PERSONALIZED MEDICINE; REVIEW;

EID: 84860691427     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.106161     Document Type: Review

References (44)

1. Vardiman JV, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasm and acute leukemia: rationale and important changes. Blood 2009;114:937-951.
2. Wan TS, Martens UM, Poon SS, Tsao SW, Chan LC, Lansdorp PM. Absence or low number of telomere repeats at junctions of dicentric chromosomes. Genes Chromosomes Cancer 1999;24:83-86.
3. Walter J, Joffe B, Bolzer A, Albiez H, Benedetti PA, Müller S, Speicher MR, Cremer T, Cremer M, Solovei I. Towards many colors in FISH on 3D-preserved interphase nuclei. Cytogenet Genome Res 2006;114:367-378.
4. Au WY, Ma SK, Wan TS, Man C, Kwong YL. Pentasomy 8q in therapy-related myelodysplastic syndrome due to cyclophosphamide therapy for fibrosing alveolitis. Cancer Genet Cytogenet 2003;141:79-82.
5. Barlett JM, Forsyth A. Detection of HER2 gene amplification by fluorescence in situ hybridization in breast cancer. Methods Mol Med 2006;120:309-22.
6. Wan TS, Ma SK, Chan GC, Chan LC. Investigation of MYCN status in neuroblastoma by fluorescence in-situ hybridization. Int J Mol Med 2004;14:981-987.
7. Wan TS, Ma ES. The impact of fluorescence in situ hybridization on the detection of genetic aberrations in haematological oncology. Journal of Hong Kong Institute of Medical Laboratory Sciences 2004;9:1-12.
8. Yip SF, Wan TS, Lie AK, Liu HS, Chan LC. Monitoring of chronic myeloid leukemia (CML) imatinib response by fluorescence in-situ-hybridization (FISH). Blood 2005;106(Part 2):289b.
9. Wan TS, Ma SK, Lee CK, Chan LC. Atypical fluorescence in-situ hybridization (FISH) pattern in chronic myeloid leukemia (CML) due to cryptic insertion of BCR at 9q34. Leukemia 2004;18:161-162.
10. Wan TS, So CC, Hui KC, Yip SF, Ma ES, Chan LC. Diagnostic utility of dual fusion PML/RARa translocation DNA probe (D-FISH) in acute promyelocytic leukemia. Oncol Rep 2007;17:799-805.
11. So CC, Wan TS, Yip SF, Chan LC. A dual colour dual fusion fluorescence in situ hybridization study on the genesis of complex variant translocations in chronic myelogenous leukaemia. Oncol Rep 2008;19:1181-1184.
12. Wan TS, Ma SK, Chow EY, Li YH, Lin SY, Chan LC. Pathogenesis of jumping translocations: a molecular cytogenetics study. Leuk Res 2004;28:1075-1079.
13. Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, Wallis J, Chen K, Payton JE, Fulton RS, Veizer J, Schmidt H, Vickery TL, Heath S, Watson MA, Tomasson MH, Link DC, Graubert TA, DiPersio JF, Mardis ER, Ley TJ, Wilson RK. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 2011;305:1577-1584.
14. Wan TS, Ma SK, Au WY, Chan LC. Derivative chromosome 9 deletions in chronic myeloid leukaemia: interpretation of atypical D-FISH pattern. J Clin Pathol 2003;56: 471-474.
15. Smoley SA, Brockman SR, Paternoster SF, Meyer RG, Dewald GW. A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia. Cancer Genet Cytogenet 2004;148:1-6.
16. Leung R, Chow EE, Au WY, Chow C, Kwong YL, Lin SY, Ma ES, Wan TS, Wong KF CD4(+)/CD56(+) hematologic malignancy with rearranged MLL gene. Hum Pathol 2006;37:247-249.
17. Ma SK, Wan TS, Au WY, Fung LF, So CK, Chan LC. Chromosome 11q deletion in myeloid malignancies. Leukemia 2002;16:953-955.
18. Ma SK, Wan TS, Cheuk AT, Fung LF, Chan GC, Chan SY, Ha SY, Chan LC. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study. Leukemia 2001;15:1442-1447.
19. Philips JL, Richardson IC. Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice. BJU Intl 2006;98:33-37.
20. Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF American Society of Clinical Oncology/College of American Pathologists guideline recommendations for huamn epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-145.
21. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor positive primary breast cancer. J Natl Cancer Inst 2003;95:142-153.
22. Bilous M, Dowsett M, Hanna W, Isola J, Lebeau A, Moreno A, Penault-Llorca F, Rüschoff J, Tomasic G, van de Vijver M. Current perspectives on HER2 testing: a review of national testing guidelines. Mod Pathol 2003;16:173-182.
23. Di Bona E, Montaldi A, Guercini N Rossi V, Luciano A, Biondi A, Rodeghiero F A (15;17)translocation not associated with acute promyelocytic leukemia. Br J Haematol 1996;95:706-709.
24. Ma ES, Au WY, Wan TS, Kwong YL, Chan LC. Translocation (15;17)(q22;q21) not associated with acute promyelocytic leukemia and negative fro PML/RARA rearrangement. Haematologica 2000;85:768-769.
25. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-497.
26. Speicher MR, Ballard SG, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996;12:368-375.
27. Wan TS, Ma SK, Chan GC, Ching LM, Ha SY, Chan LC. Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: resolution by spectral karyotyping. Cancer Genet Cytogenet 2000;118:24-27.
28. Wan TS, Ma, SK, Yip SF, Yeung YM, Chan LC. Two novel balanced chromosomal translocations in myeloid malignancies: characterization by multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 2002;139: 52-56.
29. Wan TS, Ma SK, Yip SF, Yeung YM, Chan LC. Molecular characterization of der(15)t(11;15) as a secondary cytogenetic abnormality in acute promyelocytic leukemia with cryptic PML-RARa fusion on chromosome 17q. Cancer Genet Cytogenet 2000;121:90-93.
30. Muller S, O'Brien PC, Ferguson-Smith MA, Wienberg J. Cross-species colour segmenting: a novel tool in human karyotype analysis. Cytometry 1998;33:445-52.
31. Chudoba I, Plesch A, Lörch T, Lemke J, Claussen U, Senger G. High resolution multicolor-banding: a new technique for refined FISH analysis of human chromosomes. Cytogenet Cell Genet 1999;84:156-160.
32. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Compararive genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.
33. Lu YJ, Williamson D, Clark J, Wang R, Tiffin N, Skelton L, Gordon T, Williams R, Allan B, Jackman A, Cooper C, Pritchard-Jones K, Shipley J. Comparative expressed sequenced hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. Proc Natl Acad Sci USA 2001;98: 9197-9202.
34. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-211.
35. Lockwood WW, Chari R, Chi B, Lam WL. Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet 2006;14:139-148.
36. Dhami P, Coffey AJ, Abbs S, Vermeesch JR, Dumanski JP, Woodward KJ, Andrews RM, Langford C, Vetrie D. Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome. Am J Hum Genet 2005;76:750-762.
37. Gribble SM, Kalaitzopoulos D, Burford DC, Prigmore E, Selzer RR, Ng BL, Matthews NS, Porter KM, Cyrley R, Lindsay SJ, Baptista J, Richmond TA, Carter NP. Ultrahigh resolution array painting facilitates breakpoint sequencing. J Med Genet 2007;44:51-58.
38. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM, Aburatani H, Jones KW, Tyler-Smith C, Hurles ME, Carter NP, Scherer SW, Lee C. Copy number variation: new insights in genome diversity. Genome Res 2006;16:949-961.
39. Watson SK, Deleeuw RJ, Horsman DE, Squire JA, Lam WL. Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 2007;120:795-805.
40. Peeper D, Berns A. Cross-species oncogenomics in cancer gene identification. Cell 2006;125:1230-1233.
41. Döhner H, Stilgenbauer S, Benner A Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916.
42. Dimopoulos M, Kyle R, Fermand J-P, Rajkumar V, San Miguel J, Chanan-Khan A, Ludwig H, Joshua D, Mehta J, Gertz M, Avet-Loiseau H, Beksac M, Anderson KC, Moreau P, Singhal S, Goldschmidt H, Boccadoro M, Kumar S, Giralt S, Munshi NC, Jagannath S, on behalf of the International Myeloma Workshop Consensus. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 2011;117:4701-4705.
43. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007;448:561-566.
44. Shaw AT, Yeap BY, Mino-Kenudson M, Digumarthy SR, Costa DB, Heist RS, Solomon B, Stubbs H, Admane S, McDermott U, Settleman J, Kobayashi S, Mark EJ, Rodig SJ, Chirieac LR, Kwak EL, Lynch TJ, Iafrate AJ. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009;27: 4247-4253.